KCNQ1 rs121908757: What Your Genotype Means
The rs121908757 variant is an ultra-rare single nucleotide change located in the KCNQ1 gene on chromosome 11. It has been documented in clinical and research records in connection with Romano-Ward syndrome (long QT syndrome type 1), an inherited cardiac condition characterized by delayed electrical repolarization of the heart. Because current published evidence for this specific variant remains limited, it is interpreted cautiously within clinical genetic frameworks.
What each genotype means
Typical KCNQ1 profile
This genotype represents the most common sequence found in the general population for this specific location in the KCNQ1 gene. It is not associated with the increased risk of Romano-Ward syndrome or long QT syndrome type 1 described in clinical literature for this variant.
This is the predominant genotype observed globally, carried by the vast majority of individuals.
Potential clinical significance
This genotype indicates the presence of one copy of the variant, which has been associated with a predisposition to Romano-Ward syndrome and long QT syndrome type 1. Because KCNQ1 variants can have variable clinical expression, you should discuss these results with a cardiologist or genetic counselor to understand your specific health context.
This genotype is extremely rare, with a global minor allele frequency reported as less than 0.00001 in large population databases like gnomAD.
High clinical risk profile
This genotype indicates the presence of two copies of the variant, which may significantly increase the risk of cardiac rhythm disturbances such as long QT syndrome. Individuals with mutations on both KCNQ1 alleles are considered a high-risk subgroup and should consult with a cardiac specialist for clinical evaluation.
This genotype is exceptionally rare and is not expected to be found in the general population.
What is rs121908757 and Where is it Located?
The single nucleotide polymorphism rs121908757 represents a specific DNA alteration within the KCNQ1 gene, located on the short arm of chromosome 11 (11p15.4). Variants cataloged under this identifier involve changes within the coding sequence of the gene, which provides instructions for building essential subunits of potassium voltage-gated ion channels. Unlike common polymorphic markers that appear frequently across healthy populations, rs121908757 is exceptionally rare. In genomic databases such as dbSNP and ClinVar, rare variations in this genetic region are evaluated primarily for their potential to alter amino acid sequences and disrupt the structural integrity of the channel protein, which is critical for healthy myocardial physiology.
The Biological Role of the KCNQ1 Gene
The KCNQ1 gene encodes the pore-forming alpha subunit of the Kv7.1 voltage-gated potassium channel. In cardiac myocytes, this channel interacts with auxiliary beta subunits to generate the slow delayed rectifier potassium current, commonly known as IKs. This electrical current plays a vital physiological role in the repolarization phase of the cardiac action potential, ensuring that ventricular heart muscle cells properly reset their electrical charge after every contraction. When channels formed by KCNQ1 fail to transport potassium ions efficiently—especially during rapid heart rates triggered by exercise or emotional stress—the electrical recovery period of the ventricles lengthens, predisposing the heart to dangerous arrhythmogenic rhythms.
Associated Health Conditions and Strength of Evidence
Pathogenic alterations in KCNQ1 are the leading cause of Romano-Ward syndrome, the autosomal dominant form of congenital long QT syndrome type 1 (LQT1). Patients with LQT1 have a prolonged QT interval on an electrocardiogram (ECG) and face an elevated risk of syncope, polymorphic ventricular tachycardia (such as Torsades de Pointes), and sudden cardiac arrest. ClinVar and medical genetics literature note that while the broader link between KCNQ1 loss-of-function and LQT1 is definitive, evidence for individual ultra-rare alleles such as rs121908757 is classified as limited due to small sample sizes and scarce family segregation data. Consequently, clinical laboratories interpret this variant with prudence using ACMG/AMP scoring guidelines.
Population Frequency and Ancestral Patterns
According to broad population sequencing efforts aggregated by the Genome Aggregation Database (gnomAD), the rs121908757 variant is exceedingly uncommon, demonstrating an overall global minor allele frequency (MAF) of less than 0.00001 (fewer than 1 in 100,000 individuals). Because it is so scarce, large-scale population genetics repositories do not display significant ancestry-specific hotspots or common demographic patterns. Nearly all individuals across global reference populations carry the standard reference genotype, underscoring that functional missense or disruptive changes in critical cardiac potassium channel regions are strongly selected against during human evolution.
Interpreting Your Genetic Data Responsibly
Carrying an atypical variant in KCNQ1 should never be treated as an automatic diagnosis of long QT syndrome or a guarantee of sudden cardiac events. Incomplete penetrance and variable expressivity are common in Romano-Ward syndrome, meaning some individuals with predisposing alleles remain completely asymptomatic or present with borderline QT intervals on an ECG. Furthermore, raw data from direct-to-consumer genetic testing platforms can suffer from technical artifacts, especially when assaying ultra-rare variants. Anyone who identifies this variant in raw genetic reports should consult a certified genetic counselor or a cardiologist for clinical-grade Sanger confirmation and comprehensive cardiac evaluation before making any medical decisions.
How common is this variant?
The rs121908757 variant is an ultra-rare allele with a global minor allele frequency below 0.00001 in gnomAD, with virtually all individuals worldwide carrying the homozygous reference genotype.
Frequently asked questions
What is Romano-Ward syndrome?
Romano-Ward syndrome is the most common form of congenital long QT syndrome, typically inherited in an autosomal dominant pattern. It causes delayed electrical recharge of the heart muscle without the hearing loss found in other recessive syndromes like Jervell and Lange-Nielsen syndrome.
Does having the rs121908757 variant mean I have long QT syndrome?
No, a genetic variant is not a clinical diagnosis. Long QT syndrome is diagnosed based on clinical evaluation, family history, and electrocardiogram (ECG) measurements, as some variant carriers may never develop symptoms due to incomplete penetrance.
How common is this specific KCNQ1 variant?
The rs121908757 variant is exceptionally rare, appearing in fewer than 1 in 100,000 individuals in large genomic surveys such as gnomAD. Almost everyone in the general population carries two copies of the standard reference allele.
What steps should I take if this variant appears in my raw genetic data?
You should not make lifestyle or medication changes based solely on raw consumer genetic files. Instead, share the report with a medical professional, such as a genetic counselor or cardiologist, who can order confirmatory clinical-grade sequencing and an ECG if appropriate.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908757?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in KCNQ1
A rare variant in the KCNQ1 gene associated with Long QT syndrome.
Pathogenic missense variant associated with Long QT syndrome type 1.
This variant is associated with Long QT syndrome 1, a condition affecting the heart's electrical activity.
Intronic variant in KCNQ1 associated with type 2 diabetes susceptibility and fasting glucose levels.
Truncating variant p.Arg518Ter in KCNQ1 associated with Long QT Syndrome type 1.
Associated with type 2 diabetes risk and regulation of pancreatic beta-cell insulin secretion.